Summary Pulmonary hypertension due to left heart disease, also known as group 2 pulmonary hypertension according to the European Society of Cardiology/European Respiratory Society classification, is the most common cause…
Summary Background Diagnosis of hypertrophic cardiomyopathy (HCM) in athletes can be challenging. Aims To ascertain parameters that differentiate patients with HCM from athletes with moderate left ventricular (LV) hypertrophy (LVH…
Summary Nowadays, guidelines are derived from the findings of randomized controlled therapeutic trials. However, an overall significant P value does not exclude that some patients may be harmed by or…
Summary Background Inflammation is involved during acute myocardial infarction, and could be an interesting target to prevent ischaemia-reperfusion injuries. Colchicine, known for its pleiotropic anti-inflammatory effects, could decrease systemic inflammation…
Summary Background Transcarotid access is an alternative route for transcutaneous aortic valve implantation (TAVI) in patients with impossible transfemoral access. Aims We evaluated the safety, effectiveness and early and late…
Summary Background Cardiovascular disease is the primary cause of death in women. Prevention, screening and diagnosis are generally implemented at later stages and less frequently than in men, and provision…
Summary Background The FAST-MI programme, consisting of 1-month surveys of patients admitted to hospital for acute myocardial infarction (AMI) in France, has run since 2005. Aim To gather data on…
Since 1995 and the work of Haissaguerre et al. demonstrating the venous origin of ectopic impulses triggering atrial fibrillation (AF), pulmonary vein isolation (PVI) has become the cornerstone of AF…
